{
    "code": "52027434",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027434",
    "time": "2020-02-26 06:35:24",
    "許可證字號": "衛部藥輸字第027434號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/05\/17",
    "發證日期": "107\/05\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202743401",
    "中文品名": "&quot;山德士&quot;帕瘤鎖注射劑6毫克\/毫升",
    "英文品名": "Paclitaxel Injection 6mg\/ml Sandoz",
    "適應症": "晚期卵巢癌、腋下淋巴轉移之乳癌，作為接續含杜薩魯比辛(doxorubicin)在內之輔助化學療法、已使用合併療法(除非有禁忌，至少應包括使用anthracycline抗癌藥)失敗的轉移乳癌、非小細胞肺癌、愛滋病相關卡波西氏肉瘤之第二線療法；與CISPLATIN併用，作為晚期卵巢癌之第一療法。與GEMCITABINE併用，可使用於曾經使用過anthracycline之局部復發且無法手術切除或轉移性之乳癌病患、與Herceptin併用時，用於治療未接受過化學治療之轉移性且乳癌過度表現HER-2之病人。",
    "劑型": "270注射劑",
    "包裝": "5毫升、16.7毫升、25毫升、35毫升、50毫升、100毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "監視期滿學名藥",
    "主製造廠": {
        "限制項目": "02輸　入 24監視期滿學名藥",
        "申請商名稱": "0924601100  台灣諾華股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號8樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000100",
            "成分名稱": "PACLITAXEL",
            "含量描述": "",
            "含量": "6.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Paclitaxel vial pictures for TW-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "帕瘤鎖注射劑-仿單(TWI-060618)(46190236-01)-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=001&Type=9"
        },
        {
            "title": "帕瘤鎖6-600毫克100毫升-FB-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=006&Type=8"
        },
        {
            "title": "帕瘤鎖6-300毫克50毫升-FB-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=005&Type=8"
        },
        {
            "title": "帕瘤鎖6-210毫克30毫升-FB-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=004&Type=8"
        },
        {
            "title": "帕瘤鎖6-150毫克25毫升-FB-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=003&Type=8"
        },
        {
            "title": "帕瘤鎖6-100毫克16.7毫升-FB-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=002&Type=8"
        },
        {
            "title": "帕瘤鎖6-30毫克5毫升-FB-107-10-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027434&Seq=001&Type=8"
        }
    ]
}